"What are the 'good,' 'bad,' and 'ugly' scenarios for the future of Covid-19?" That's the question Advisory Board experts first tried to answer in an article published one year ago today. Now, we look back to evaluate what we got right, what we got wrong—and what the experience taught us about predicting the next phase of the pandemic.
On Friday, British researchers released early data that suggests while the omicron BA.2 subvariant, which has been widely referred to as "stealth" omicron, is more transmissible than the original BA.1 variant, vaccines remain equally effective against both strains.
Despite a significant push towards value-based care in recent years, many health systems still largely compensate physicians based on the volume of their services, according to a new study from RAND Corporation.
Pfizer and BioNTech are expected to ask FDA for an emergency use authorization of their Covid-19 vaccine for children ages 6 months to 5 years old. But amid a stalled child vaccination campaign, will parents vaccinate their young children?
Family planning and fertility benefits have historically been excluded from most employer-sponsored health care plans—but a new survey from Mercer suggests that lower treatment costs and employers' prioritization of diversity, equity, and inclusion initiatives have made fertility services a rising workplace benefit.
Poor hospital readmission rates are often attributed to factors such as socioeconomic status, access to care, and insurance coverage. However, a study published Friday in JAMA Health Forum found that community and social factors have only a modest effect on readmission rates.